Treating Intraoperative Bradycardia in Non-cardiac Surgery Patients With Atropine at Heart Rates Below 60 Versus 30 Beats Per Minute and Norepinephrine Requirements
RAPID
1 other identifier
interventional
186
1 country
1
Brief Summary
The RAPID trial is a randomized, single-center trial investigating whether giving atropine at heart rates below 60 beats per minute versus giving atropine only at heart rates below 30 beats per minute reduces the amount of norepinephrine needed to keep MAP above 65 mmHg in non-cardiac surgery patients with intraoperative bradycardia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 23, 2025
CompletedStudy Start
First participant enrolled
April 7, 2025
CompletedFirst Posted
Study publicly available on registry
April 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 11, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 16, 2025
CompletedApril 29, 2026
April 1, 2025
7 months
March 23, 2025
April 27, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Average norepinephrine infusion rate
Average norepinephrine infusion rate in μg per kg actual body weight per minute (μg kg-1 min-1) needed to keep MAP above 65 mmHg from anesthetic induction until the end of surgery (continuous outcome)
Perioperative
Secondary Outcomes (4)
Time-weighted average MAP <65 mmHg
Perioperative
Time-weighted average heart rate <60 bpm
Perioperative
Time-weighted average MAP >110 mmHg
Perioperative
Time-weighted average heart rate >100 bpm
Perioperative
Other Outcomes (5)
Incidence of acute kidney injury
Within the first 3 postoperative days
Incidence of delirium
Within the first 3 postoperative days
Incidence of urinary retention
Within the first 3 postoperative days
- +2 more other outcomes
Study Arms (2)
Giving atropine at heart rates below 60 beats per minute
EXPERIMENTALGiving atropine at heart rates below 30 beats per minute
ACTIVE COMPARATORInterventions
In patients assigned to the atropine therapy at heart rates below 60 beats per minute, atropine will be given at a dose of 0.5 mg when heart rate is below 60 beats per minute for one continuous minute. A second and third atropine dose of 0.5 mg will be given if heart rate remains or again drops below 60 beats per minute for one continuous minute. Patients will not be given more than 1.5 mg atropine.
In patients assigned to atropine therapy at heart rates below 30 beats per minute, atropine will be given at a dose of 0.5 mg when heart rate is below 30 beats per minute for one continuous minute. A second and third atropine dose of 0.5 mg will be given if heart rate remains or again drops below 30 beats per minute for one continuous minute. Patients will not be given more than 1.5 mg atropine.
Eligibility Criteria
You may qualify if:
- Age ≥65 years
- American Society of Anesthesiologists physical status III or IV
- Chronic arterial hypertension
- Diabetes mellitus requiring medication
- Intraabdominal surgery
- Preoperative renal insufficiency (serum creatinine ≥1.2 mg/dL)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Medical Center Hamburg-Eppendorf
Hamburg, 20246, Germany
Study Officials
- PRINCIPAL INVESTIGATOR
Alina Bergholz, MD
University Medical Centre Hamburg-Eppendorf
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
March 23, 2025
First Posted
April 10, 2025
Study Start
April 7, 2025
Primary Completion
November 11, 2025
Study Completion
December 16, 2025
Last Updated
April 29, 2026
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share